Windtree Therapeutics's market cap is currently ―. The company's EPS TTM is $-8.12; its P/E ratio is -0.04; Windtree Therapeutics is scheduled to report earnings on May 15, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	-	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -4.41M	$ -6.59M	$ 4.28M	$ -11.10M	$ -4.04M
EBITDA	$ -4.30M	-	$ 4.42M	$ -10.96M	$ -4.02M
Net Income Common Stockholders	$ -4.42M	$ -6.60M	$ 4.27M	$ -9.67M	$ -4.06M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 7.37M	$ 11.47M	$ 4.24M	$ 6.17M	$ 8.44M
Total Assets	$ 36.06M	$ 40.58M	$ 34.95M	$ 37.95M	$ 48.10M
Total Debt	$ 2.16M	$ 2.50M	$ 1.90M	$ 2.28M	$ 2.78M
Net Debt	$ -5.21M	$ -8.97M	$ -2.33M	$ -3.89M	$ -5.66M
Total Liabilities	$ 28.57M	$ 28.97M	$ 28.16M	$ 27.94M	$ 30.68M
Stockholders Equity	$ 7.48M	$ 11.60M	$ 7.03M	$ 10.01M	$ 17.42M
Cash Flow	-
Free Cash Flow	$ -3.87M	-	$ -2.52M	$ -3.38M	$ -4.10M
Operating Cash Flow	$ -3.85M	$ -3.50M	$ -2.52M	$ -3.38M	$ -4.10M
Investing Cash Flow	$ -15.00K	-	-	-	$ 0.00
Financing Cash Flow	$ -233.00K	$ 10.72M	$ 591.00K	$ 1.12M	$ 1.16M

Currency in USD

Windtree Therapeutics Earnings and Revenue History

Income Statement >

Windtree Therapeutics Debt to Assets

Balance Sheet >

Windtree Therapeutics Cash Flow

Cash Flow >

Windtree Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing